Speakers
Head of Scientific Evidence Generation, European Medicines Agency, Netherlands
The Scientific Evidence Generation Department aims to support the development of medicines to ensure generation of robust and relevant scientific evidence, also in collaboration with other stakeholders. Activities include the provision of scientific advice & methodology qualification...
Read More →
Scientififc Advice, Scientific Evidence Generation, Human Medicines, European Medicines Agency, Netherlands
Iordanis Gravanis is a medical doctor by training and has a PhD in molecular and cellular pharmacology. He has been at the European Medicines Agency for almost 13 years, having worked initially as scientific officer in the oncology office for 5.5 years managing managing new authorisations...
Read More →
Chair EUnetHTA Executive Board; Chief Pharmacist, Dental and Pharmaceutical Benefits Agency, TLV, Sweden
Niklas Hedberg is the Chief Pharmacist at the Swedish national governmental authority, the Dental and Pharmaceuticals Benefits Agency (TLV). He is the Chair of the EUnetHTA Executive Board and the TLV lead partner in EUnetHTA WP 3 Evaluation. Niklas has been working with pricing and...
Read More →
Head EU Regulator Affairs, Product Development, F. Hoffmann-La Roche Ltd., Switzerland
Anja is currently Head of EU Regulatory Affairs at F. Hoffmann-La Roche and her group acts as a strategic and procedural advisory body on EU questions. In her 20 years with Roche she spent most of her time in Regulatory between Headquarter and affiliate role (e.g 5 years as the DRA...
Read More →
Chief Regulatory Officer, Lysogene S.A., France
Marie Deneux is in charge of defining and executing the regulatory strategy for the development and registration of Lysogene’s gene therapy products. Prior to joining Lysogene, Marie Deneux spent 15 years in consulting, where she assisted life sciences companies throughout the development...
Read More →
Friday June 18, 2021 12:00pm - 1:00pm EDT
TBD
Virtual Event Horsham, PA 19044